Integrated Delivery of HIV Services in Sexual and Reproductive Health Clinics Targeting Key and Priority Populations and in Confidential STI Clinics for Commercial Sex Workers in Ethiopia under PEPFAR | CDC RFA GH17 1743

Opportunity Information: Apply for CDC RFA GH17 1743

The Centers for Disease Control and Prevention (CDC), through its Center for Global Health and under PEPFAR, released a discretionary funding opportunity called "Integrated Delivery of HIV Services in Sexual and Reproductive Health Clinics Targeting Key and Priority Populations and in Confidential STI Clinics for Commercial Sex Workers in Ethiopia under PEPFAR" (Funding Opportunity Number: CDC RFA GH17-1743). The award is structured as a cooperative agreement, meaning the recipient would carry out the work with substantial CDC involvement in areas like technical direction, performance monitoring, and coordination with national strategies. The opportunity is focused on Ethiopia and is designed to strengthen health service delivery for populations with elevated HIV risk and burden, with a particular emphasis on improving access, quality, and integration of services.

The main goal is to expand and strengthen comprehensive HIV prevention, care, and treatment for key and priority populations, especially female sex workers (FSWs), and also priority groups such as clients of FSWs in major urban centers and identified hot spot areas. The design centers on integrated service delivery through sexual and reproductive health (SRH) clinics and confidential sexually transmitted infection (STI) clinics tailored to commercial sex workers. Rather than treating HIV services as a stand-alone program, the grant stresses combining core HIV interventions with reproductive health and STI services so clients can receive multiple, related services in one setting, which can reduce stigma, improve uptake, and support continuity of care.

Programmatic activities highlighted in the announcement include routine STI screening and treatment, HIV counseling and testing (HCT), and the provision of antiretroviral therapy (ART) for those diagnosed with HIV. Tuberculosis (TB) screening and treatment are also prioritized, reflecting the high level of HIV/TB co-infection risk and the importance of integrated TB/HIV programming. By embedding these services into SRH platforms for key populations, the initiative aims to make prevention and treatment more accessible and consistent, while improving the overall quality of clinical care delivered in these settings.

A further emphasis is placed on prevention of mother-to-child transmission of HIV (PMTCT), positioned as a contribution to Ethiopia's national goal of eliminating mother-to-child transmission (MTCT). This suggests the supported clinics would not only focus on non-pregnant clients but also ensure that women of reproductive age, including those who may become pregnant, have clear pathways to PMTCT services when needed. The announcement also notes that HIV prevention services will be delivered as part of a broader gender-based violence (GBV) care package, recognizing that GBV and HIV vulnerability are closely linked for many women, including FSWs, and that comprehensive, trauma-informed services can improve both safety and health outcomes.

Monitoring and evaluation is a core component of the award. The FOA specifies that the M&E system will generate behavioral and biomedical sentinel surveillance data while also tracking program performance. In practice, that implies the recipient would be expected to build or strengthen systems that can monitor service delivery outputs (such as testing coverage, linkage to treatment, retention, and viral suppression where applicable), as well as collect periodic data that helps characterize trends in risk behaviors and biomedical indicators within the target populations. This dual focus supports both real-time program improvement and longer-term public health understanding of the epidemic among key and priority populations in Ethiopia.

Administratively, the opportunity lists eligibility as unrestricted, indicating that a wide range of applicant organizations could apply if they meet standard U.S. government requirements. The agency is the CDC (CGH). The award ceiling is listed as $2,250,000, with an expectation of one award. The original closing date shown is April 23, 2020, and the opportunity record indicates a creation date of August 8, 2016. Overall, the grant is aimed at delivering integrated, confidential, and targeted clinical services that connect STI care, HIV testing and treatment, TB services, reproductive health, PMTCT, and GBV-related prevention and support into a cohesive package for populations most affected by HIV in Ethiopia, while producing strong performance monitoring and sentinel surveillance data to guide and validate impact.

• The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Integrated Delivery of HIV Services in Sexual and Reproductive Health Clinics Targeting Key and Priority Populations and in Confidential STI Clinics for Commercial Sex Workers in Ethiopia under PEPFAR" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2016-08-08.
• Applicants must submit their applications by 2020-04-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $2,250,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for CDC RFA GH17 1743

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: